期刊文献+

DNA甲基化和非编码RNA在肝细胞癌转移复发中的研究进展 被引量:1

Research progress of DNA methylation and non-coding RNA in the metastasis and recurrence of hepatocellular carcinoma
下载PDF
导出
摘要 转移和复发是影响肝细胞癌(肝癌)患者生存的主要因素,目前,肝癌的复发转移机制取得了一些进展,表观遗传学调控在DNA甲基化/羟甲基化修饰、组蛋白修饰、染色质重塑及非编码RNA表达等方面起重要作用,其中DNA甲基化和非编码RNA在肝癌转移复发中的作用研究较多,笔者简要综述DNA甲基化和非编码RNA在肝癌转移复发中的研究进展。 Objective: Metastasis and recurrence are the main factors affecting the survival of patients with hepatocellular carcinoma(liver cancer), at present, rhe mechanism of hepatocellular carcinoma recurrence and metastasis have gotten some progress. The epigenetic regulation plays an important role in DNA methylation / hydroxyl methylation, histone modification, chromatin remodeling and expression of non-coding RNA etc.,among them, the researchers pay more attention on how DNA methylation and non-coding RNA to affect the liver cancer metastasis and recurrence. The author reviews DNA methylation and non-coding RNA in the recurrence and metastasis of liver cancer research progress.
作者 廖维甲
出处 《华夏医学》 CAS 2014年第1期221-224,共4页 Acta Medicinae Sinica
基金 国家自然科学基金项目(81260328 81372163) 桂林市科学研究与技术开发计划项目(20100128-5)
关键词 肝细胞癌 转移 复发 DNA甲基化 非编码RNA hepatocellular carcinoma metastasis recurrence DNA methylation non-coding RNA
  • 相关文献

参考文献26

  • 1Fomer A, Llovet J M, Bruix J. Hepatocellular carcinoma [J]. Lancet, 2012, 379:1245-1255.
  • 2Kwon G Y, Yoo B C, Koh K C, et al. Promoter methyl ation of E-cadherin in hepatocellular carcinomas and dys plastic nodules[J]. J Korean Med Sci, 2005, 20(2):242-247.
  • 3Lu B, Ma Y, Wu G, et al. Methylation of Tip30 promot- er is associated with poor prognosis in human hepatocel- lular carcinoma[J]. Clin Cancer Res, 2008, 14 (22) 7405-7412.
  • 4Kanda M, Nomoto S, Oya H, et al. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma[J]. Int J Oncol, 2014, 44(1):44-52.
  • 5Liao W, Liu W, Yuan Q, el al. Silencing of DLGAP5 by siRNA Significantly Inhibits the Proliferation and Inva- sion of Hepatocellular Carcinoma Cells[J]. PLoS One, 2013, 8(12) :e80789.
  • 6Tahiliani M, Koh K P, Shen Y, et al. Conversion of 5- methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TETI[J]. Science, 2009, 324 (5929) : 930-935.
  • 7Kriaucionis S, Heintz N. The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain[J]. Science, 2009, 324(5929):929-930.
  • 8Liu C, Liu L, Chen X, et al. Decrease of 5-hydroxymeth- ylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1 [J]. PLoS One, 2013, 8(5) :e62828.
  • 9Chen M L, Shen F, Huang W, et al. Quantlllcatlon of 5- methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry[J]. Clin Chem, 2013, 59(5) : 824-832.
  • 10Zhang X, Liu S, Hu T, et al. Up-regulated microRNA 143 transcribed by nuclear factor kappa B enhances hepa tocarcinoma metastasis by repressing fibronectin expres sion[J]. Hepatology, 2009, 50(2):490-499.

同被引文献19

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部